- Report
- February 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Book
- January 2016
North America
The Pediatric Infectious Disease market is a subset of the larger Pediatrics market, focusing on the diagnosis, treatment, and prevention of infectious diseases in children. This includes a wide range of diseases, from common illnesses such as the flu and strep throat to more serious conditions such as HIV and tuberculosis. Treatment options vary depending on the type of infection, and may include antibiotics, antivirals, and other medications. Vaccines are also an important part of prevention and control of pediatric infectious diseases.
Companies in the Pediatric Infectious Disease market include pharmaceutical companies such as Pfizer, Merck, and GlaxoSmithKline, as well as medical device companies such as Becton Dickinson and Abbott Laboratories. Additionally, there are a number of biotechnology companies that specialize in the development of treatments for pediatric infectious diseases, such as Gilead Sciences and Moderna Therapeutics. Show Less Read more